AMRIZE LTD
AMRZNYSETrading Snapshot
- Day Range
- $37.54 – $38.06
- 52-Week Range
- $36.87 – $65.94
- Volume
- $1.86B
- Avg Volume
- $2.30B
- Shares Outstanding
- 553.5M
- Next Earnings
- Oct 31, 2026
Fundamentals Snapshot
- Annual Revenue
- $11.81B
- Last Q Revenue
- $3.49B
- P/E Ratio
- —
- P/S Ratio
- —
- EPS (TTM)
- —
- Dividend Yield
- —
- Dilution (1yr)
- +0.0%
Why Investors Own AMRZ
- ✓High-growth profile — revenue up +47.1% YoY with expanding US Equity exposure.
- ✓Healthy economics — 71% gross margin and 29% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
AMRIZE LTD
AMRZ
StockOtter · stockotter.spaceAbout AMRIZE LTD
Amrize AG engages in the provision of various building solutions for infrastructure, commercial, and residential construction markets in North America and Canada. It operates through two segments, Building Materials and Building Envelope. The Building Materials segment offers cement and aggregates, as well as ready-mix concrete, asphalt, and other construction materials. The Building Envelope segment provides advanced roofing and wall systems, including single-ply membranes, insulation, shingles, sheathing, waterproofing, and protective coatings; and adhesives, tapes, and sealants. The company was formerly known as Holcim North America Finance Ltd and changed its name to Amrize AG in December 2013. Amrize AG was incorporated in 2023 and is based in Zug, Switzerland.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Ratings
ⓘLatest News & Updates
New Strong Sell Stocks for September 29th
APLD, CVCO and AMRZ have been added to the Zacks Rank #5 (Strong Sell) List on September 29, 2026.
Amrize: Healthy End Markets And Margin Recovery Support The Upside
Amrize is rated Buy, driven by robust commercial and infrastructure demand, capacity expansion, and strategic M&A positioning for multi-year growth. Building Envelope margins are set to recover as recent price increases
Amrize CEO Jan Philipp Jenisch Buys 30,000 Shares for $1.3 Million. Is This a Buy Signal?
Jan Philipp Jenisch purchased 30,000 shares for a total consideration of ~$1.3 million on September 2, 2026. The transaction involved shares equal to 1% of the total equity stake held before the filing.
Do Options Traders Know Something About Amrize Stock We Don't?
Investors need to pay close attention to AMRZ stock based on the movements in the options market lately.
Amrize Appoints Mario Gross as President of Building Envelope
CHICAGO & ZUG, Switzerland--(BUSINESS WIRE)--The Amrize (NYSE: AMRZ) Board of Directors has appointed Mario Gross as President, Building Envelope, effective September 11, 2026. Gross succeeds Jake Gosa, who is stepping d
Here Are Wednesday’s Top Wall Street Analyst Research Calls: Ally Financial, GitLab, GLOBAL FOUNDRIES, Martin Marietta Materials, Rocket Lab USA, Strategy, Toast, Tower Semiconductor, and More
Markets took a beating Tuesday as war tensions, surging oil, and the September curse hammered stocks, bonds, and gold all at once. Find out which stocks Wall Street upgraded, downgraded, or initiated fresh coverage on as